Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,481 to 1,500 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Donor monocyte-derived macrophages promote human acute graft-versus-host disease. | J Clin Invest | 2020 | 32453711 | PubTator, text mining | PubMed |
| Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma. | Blood Cancer J | 2020 | 32444689 | PubTator, text mining | PubMed |
| The case for chronotherapy in Covid-19-induced acute respiratory distress syndrome. | Br J Pharmacol | 2020 | 32442317 | PubTator, text mining | PubMed |
| Marine Polyhydroxynaphthoquinone, Echinochrome A: Prevention of Atherosclerotic Inflammation and Probable Molecular Targets. | J Clin Med | 2020 | 32429179 | PubTator, text mining | PubMed |
| Comparative toxicity analysis of corannulene and benzo[a]pyrene in mice. | Toxicol Lett | 2020 | 32417428 | PubTator, text mining | PubMed |
| Quercetin Attenuates Atherosclerosis via Modulating Oxidized LDL-Induced Endothelial Cellular Senescence. | Front Pharmacol | 2020 | 32410992 | PubTator, text mining | PubMed |
| MAPK pathway mutations in head and neck cancer affect immune microenvironments and ErbB3 signaling. | Life Sci Alliance | 2020 | 32381551 | PubTator, text mining | PubMed |
| Upregulation of Phosphatase 1 Nuclear-Targeting Subunit (PNUTS) Is an Independent Predictor of Poor Prognosis in Prostate Cancer. | Dis Markers | 2020 | 32377272 | PubTator, text mining | PubMed |
Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages. | Front Immunol | 2020 | 32373130 | PubTator, text mining | PubMed |
| Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor. | Mol Ther Oncolytics | 2020 | 32368617 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy. | Biores Open Access | 2020 | 32368414 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group. | Front Oncol | 2020 | 32351889 | PubTator, text mining | PubMed |
| MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases. | Front Immunol | 2020 | 32351507 | PubTator, text mining | PubMed |
| Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs. | Nat Commun | 2020 | 32341343 | PubTator, text mining | PubMed |
| NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis. | Evid Based Complement Alternat Med | 2020 | 32328119 | PubTator, text mining | PubMed |
| Identification of key microRNAs and target genes for the diagnosis of bone nonunion. | Mol Med Rep | 2020 | 32319614 | PubTator, text mining | PubMed |
| Cancer cell-intrinsic expression of MHC II in lung cancer cell lines is actively restricted by MEK/ERK signaling and epigenetic mechanisms. | J Immunother Cancer | 2020 | 32312906 | PubTator, text mining | PubMed |
| CRISPR/Cas9-Mediated Foxp1 Silencing Restores Immune Surveillance in an Immunocompetent A20 Lymphoma Model. | Front Oncol | 2020 | 32309216 | PubTator, text mining | PubMed |
| miR-19 regulates the expression of interferon-induced genes and MHC class I genes in human cancer cells. | Int J Med Sci | 2020 | 32308549 | PubTator, text mining | PubMed |
| Characterising the prognostic potential of HLA-DR during colorectal cancer development. | Cancer Immunol Immunother | 2020 | 32306077 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=75